SUPRIYA LIFESCIENCE
Back to Cashflow Statement
|
SUPRIYA LIFESCIENCE Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-22 Cr | ₹-10 Cr | ₹150 Cr | ₹-15 Cr | ₹-29 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUPRIYA LIFESCIENCE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-22 Cr |
Mar2023 | ₹-10 Cr |
Mar2022 | ₹150 Cr |
Mar2021 | ₹-15 Cr |
Mar2020 | ₹-29 Cr |
How is Cash Flow from Financing Activities of SUPRIYA LIFESCIENCE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-22 Cr | Negative | |
Mar2023 | ₹-10 Cr | Negative | |
Mar2022 | ₹150 Cr | Positive | |
Mar2021 | ₹-15 Cr | Negative | |
Mar2020 | ₹-29 Cr | - |
Compare Cash Flow from Financing Activities of peers of SUPRIYA LIFESCIENCE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUPRIYA LIFESCIENCE | ₹5,369.8 Cr | -16% | 4.1% | 82.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,394.0 Cr | -6.7% | 2.6% | 5% | Stock Analytics | |
DIVIS LABORATORIES | ₹142,920.0 Cr | -6.6% | -3.7% | 43.8% | Stock Analytics | |
CIPLA | ₹114,383.0 Cr | -5.3% | -2.9% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,817.0 Cr | -3.8% | 1.8% | 25.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹91,385.4 Cr | -4.9% | -3.3% | -10.2% | Stock Analytics |
SUPRIYA LIFESCIENCE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUPRIYA LIFESCIENCE | -16% |
4.1% |
82.5% |
SENSEX | -3.6% |
-0.7% |
-0.5% |
You may also like the below Video Courses